No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SPNTSiriusPoint Ltd. | 2.38B | 20.40 | 19.62 | -3.28% | 6.98% | 8.97% | 3.13% | 0.33 |
| EGEverest Re Group, Ltd. | 13.48B | 321.21 | 10.11 | 18.06% | 3.15% | 3.59% | 36.76% | 0.43 |
| HGHamilton Insurance Group, Ltd. | 1.7B | 26.37 | 7.19 | 47.03% | 15.65% | 15.98% | 44.62% | 0.06 |
| Nov 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Revenue | 1.34B | 1.29B | 1.62B | 2.38B |
| Revenue Growth % | - | -0.04% | 0.26% | 0.47% |
| Medical Costs & Claims | 919.7M | 1.08B | 1.07B | 1.45B |
| Medical Cost Ratio % | - | - | - | - |
| Gross Profit | 416.49M | 203.51M | 547.29M | 930.82M |
| Gross Margin % | - | - | - | - |
| Gross Profit Growth % | - | -0.51% | 1.69% | 0.7% |
| Operating Expenses | 154.29M | 230.34M | 292.07M | 309.26M |
| OpEx / Revenue % | - | - | - | - |
| Depreciation & Amortization | 13.9M | 14.99M | 12.41M | 16.47M |
| Combined Ratio % | - | - | - | - |
| Operating Income | 262.2M | -26.83M | 255.22M | 621.56M |
| Operating Margin % | - | - | - | - |
| Operating Income Growth % | - | -1.1% | 10.51% | 1.44% |
| EBITDA | 276.1M | -11.84M | 267.63M | 638.03M |
| EBITDA Margin % | - | - | - | - |
| Interest Expense | 14.9M | 15.74M | 21.43M | 22.62M |
| Non-Operating Income | -14.9M | -15.74M | -21.43M | -22.62M |
| Pretax Income | 262.2M | -26.83M | 255.22M | 621.56M |
| Pretax Margin % | - | - | - | - |
| Income Tax | 12.37M | 3.1M | -25.07M | 8.4M |
| Effective Tax Rate % | - | - | - | - |
| Net Income | 188.18M | -98M | 258.73M | 400.43M |
| Net Margin % | - | - | - | - |
| Net Income Growth % | - | -1.52% | 3.64% | 0.55% |
| EPS (Diluted) | -4.20 | -0.89 | 2.44 | 3.67 |
| EPS Growth % | - | 0.79% | 3.74% | 0.5% |
| EPS (Basic) | -4.20 | -0.89 | 2.47 | 3.81 |
| Diluted Shares Outstanding | 102.56M | 109.99M | 106.04M | 101.47M |
| Nov 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Total Assets | 5.61B | 5.82B | 6.67B | 7.8B |
| Asset Growth % | - | 0.04% | 0.15% | 0.17% |
| Total Investment Assets | 3.11B | 2.29B | 3.11B | 939.38M |
| Long-Term Investments | 2.46B | 2.29B | 3.11B | 442.27M |
| Short-Term Investments | 643.86M | 0 | 428.88M | 497.11M |
| Total Current Assets | 2.52B | 2.87B | 0 | 3.86B |
| Cash & Equivalents | 797.79M | 1.08B | 794.51M | 996.49M |
| Receivables | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | -643.86M | 0 | -3.42B | 0 |
| Goodwill & Intangibles | 117.01M | 86.96M | 91M | 93.12M |
| Goodwill | 24.88M | 0 | 0 | 0 |
| Intangible Assets | 92.13M | 86.96M | 91M | 93.12M |
| PP&E (Net) | 0 | 7.8M | 0 | 9.1M |
| Other Assets | 0 | -2.37B | -3.2B | 3.39B |
| Total Liabilities | 3.82B | 4.15B | 4.62B | 5.47B |
| Total Debt | 149.88M | 149.72M | 149.83M | 149.94M |
| Net Debt | -647.92M | -926.71M | -644.68M | -846.55M |
| Long-Term Debt | 149.88M | 149.72M | 149.83M | 149.94M |
| Short-Term Debt | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 382.37M | 0 | 446.64M |
| Accounts Payable | 496.03M | 382.37M | 459.2M | 446.64M |
| Deferred Revenue | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -674.12M | -48.12M | -532.28M | -215.85M |
| Deferred Taxes | 0 | 0 | 0 | 0 |
| Other Liabilities | 3.67B | 0 | -149.83M | 4.87B |
| Total Equity | 1.79B | 1.66B | 2.05B | 2.33B |
| Equity Growth % | - | -0.07% | 0.23% | 0.14% |
| Shareholders Equity | 1.79B | 1.66B | 2.05B | 2.33B |
| Minority Interest | 150K | 119K | 133K | 128K |
| Retained Earnings | 681.66M | 547.35M | 801.37M | 1.17B |
| Common Stock | 1.02M | 1.03M | 1.1M | 1.01M |
| Accumulated OCI | -4.44M | -4.44M | -4.44M | -4.44M |
| Return on Equity (ROE) | 0.11% | -0.06% | 0.14% | 0.18% |
| Return on Assets (ROA) | 0.03% | -0.02% | 0.04% | 0.06% |
| Equity / Assets | - | - | - | - |
| Debt / Equity | 0.08x | 0.09x | 0.07x | 0.06x |
| Book Value per Share | 17.43 | 15.13 | 19.31 | 22.95 |
| Tangible BV per Share | - | - | - | - |
| Nov 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Cash from Operations | 226.53M | 190.93M | 283.15M | 759.3M |
| Operating CF Growth % | - | -0.16% | 0.48% | 1.68% |
| Operating CF / Revenue % | - | - | - | - |
| Net Income | 249.84M | -98M | 258.73M | 613.16M |
| Depreciation & Amortization | 13.9M | 14.99M | 12.41M | 16.47M |
| Stock-Based Compensation | 8.88M | 10.78M | 44.38M | 30.38M |
| Deferred Taxes | 0 | 49.61M | 0 | 0 |
| Other Non-Cash Items | -398.71M | 273.93M | -194.58M | -507.58M |
| Working Capital Changes | 352.62M | -60.4M | 162.22M | 606.87M |
| Cash from Investing | 137.82M | 133.1M | -652.09M | -184.16M |
| Capital Expenditures | 0 | 0 | 0 | 0 |
| Acquisitions | 57.43M | 0 | 0 | 0 |
| Purchase of Investments | -4.56B | -4.79B | -5.3B | -3.76B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K |
| Other Investing | -15.64M | 67.05M | -17.93M | 391.61M |
| Cash from Financing | -68M | -69.62M | 59.02M | -362.69M |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | -7.38M | -1.52M | -2.44M | -150.35M |
| Stock Issued | 1.01M | 315K | 83M | 396K |
| Debt Issuance (Net) | 0 | -345K | 0 | 0 |
| Other Financing | -61.63M | -68.07M | -21.55M | -212.73M |
| Net Change in Cash | 294.85M | 243.08M | -306.34M | 199.99M |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K |
| Cash at Beginning | 660.08M | 964.13M | 1.21B | 900.86M |
| Cash at End | 954.93M | 1.21B | 900.86M | 1.1B |
| Free Cash Flow | 226.53M | 190.93M | 283.15M | 759.3M |
| FCF Growth % | - | -0.16% | 0.48% | 1.68% |
| FCF Margin % | - | - | - | - |
| FCF per Share | 2.21 | 1.74 | 2.67 | 7.48 |
| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Combined Ratio | 80.38% | 102.08% | 84.23% | 73.87% |
| Medical Cost Ratio | 68.83% | 84.2% | 66.18% | 60.87% |
| Return on Equity (ROE) | 10.53% | -5.68% | 13.94% | 18.3% |
| Return on Assets (ROA) | 3.35% | -1.71% | 4.14% | 5.54% |
| Equity / Assets | 31.86% | 28.6% | 30.7% | 29.87% |
| Book Value / Share | 17.43 | 15.13 | 19.31 | 22.95 |
| Debt / Equity | 0.08x | 0.09x | 0.07x | 0.06x |
| Revenue Growth | - | -3.64% | 25.67% | 47.03% |
| 2023 | 2024 | |
|---|---|---|
| BERMUDA | 615.02M | 847.79M |
| BERMUDA Growth | - | 37.85% |
Hamilton Insurance Group, Ltd. (HG) has a price-to-earnings (P/E) ratio of 7.2x. This may indicate the stock is undervalued or faces growth challenges.
Hamilton Insurance Group, Ltd. (HG) grew revenue by 47.0% over the past year. This is strong growth.
Yes, Hamilton Insurance Group, Ltd. (HG) is profitable, generating $438.4M in net income for fiscal year 2024 (16.8% net margin).
Hamilton Insurance Group, Ltd. (HG) has a return on equity (ROE) of 18.3%. This is reasonable for most industries.
Hamilton Insurance Group, Ltd. (HG) has a combined ratio of 73.9%. A ratio below 100% indicates underwriting profitability.